Home Meetings & Conferences Other Gasotransmitter Conferences

Thu,03Sep2015

Other Gasotransmitter Conferences

Upcoming

9th Biennual Conference on the Biology, Chemistry and Therapeutic Applications of NO, Sendai Japan, 2016  
9th International Conference on Heme Oxygenases Prague September 14-17, 2016
Society for Free Radical Research Europe, June 8-11, 2016 Hungary (H2S symposium with BM1005 participation)
4th International H2S meeting, Naples 3-5 June 2016
Experimental Biology 2016, San Diego 2-6 April, 2016 Symposium on H2S, with BM1005 participation
Pharmacology 2015, December 15-17, 2015 (H2S symposium with BM1005 participation)

Past

Physiologogy 2015 (Motorpoint Arena Cardiff, UK 6 to 8 July) with BM1005 participation
3rd European Conference on the Biology of Hydrogen Sulfide, May 3-6, 2015, Athens, Greece.
8th international Conference on Heme Oxygenases, BioIron and Oxidative Stress, October 8-11, 2014, Sydney, Australia.
International Symposium “Gasotransmitters: Physiology and Pathophysiology, September 21-23, 2014, Kazan, Russia.
Nitric Oxide - Nitrite/Nitrate Conference, June 16-20, 2014, Cleveland, USA.
3rd International Conference on Hydrogen Sulfide in Biology and Medicine, June 4-6, 2014, Kyoto, Japan.
2nd European Conference on the Biology of Hydrogen Sulfide, 8th-11th September 2013, University of Exeter, England.
6th International Conference on cGMP cGMP: Generators, Effectors and Therapeutic Implications, Erfurt-Germany, June 28-30, 2013.
2nd International Conference on H2S Biology and Medicine, Atlanta, GA, September 20-22, 2012.
7th International Conferene on the Biology, Chemistry and Therapeutic Applications of Nitric Oxide, Edinburgh, Scotland July 22-26, 2012
1st European Conference on the Biology of H2S, Smolenice, Slovakia, June 15-18, 2012
7th International Meeting on Heme Oxygenases and Related Enzymes, Edinburgh, May 28– June 1 2012
British Pharmacological Society Winter Meeting, December 13-15, London, UK, Symposium on gasotransmitters (Gasotransmitters as physiological mediators and therapeutic agents: the challenges ahead)

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.